Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma

被引：0
|
作者：
Tim A. Labeur
R. Bart Takkenberg
Heinz-Josef Klümpen
Otto M. van Delden
机构：
[1] Cancer Center Amsterdam,Department of Medical Oncology, Amsterdam University Medical Centers
[2] University of Amsterdam,Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers
[3] University of Amsterdam,Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers
[4] University of Amsterdam,undefined
来源：
CardioVascular and Interventional Radiology | 2019年 / 42卷
关键词：
Hepatocellular carcinoma; Transarterial chemoembolization; TACE; Discontinuation; Time to untreatable progression by chemoembolization; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：230 / 238
页数：8
相关论文
共 50 条
  • [41] Transarterial chemoembolization for hepatocellular carcinoma
    Lau, WY
    Yu, SCH
    Lai, ECH
    Leung, TWT
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 202 (01) : 155 - 168
  • [42] TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA
    Vremera, Teodora
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (01): : 182 - 182
  • [43] Fever is not good after transarterial chemoembolization for hepatocellular carcinoma
    Yang, Hung-Chih
    ADVANCES IN DIGESTIVE MEDICINE, 2020, 7 (02) : 56 - 57
  • [44] PLEURITIS AND EMPYEMA AFTER TRANSARTERIAL CHEMOEMBOLIZATION OF HEPATOCELLULAR CARCINOMA
    Channick, Jessica E.
    Brownstein, Adam J.
    Wilcox, Chad S.
    Zhong, Jin
    Hoo, Guy W. Soo
    CHEST, 2022, 162 (04) : 1391A - 1392A
  • [45] Hepatic Decompensation After Transarterial Chemoembolization For Hepatocellular Carcinoma
    Hughes, Dempsey
    Gordon, Fredric D.
    Stuart, Keith E.
    Nugent, F. W.
    Flake, Sebastian
    Simpson, Mary Ann
    Qamar, Amir A.
    HEPATOLOGY, 2015, 62 : 417A - 418A
  • [46] A rare complication after transarterial chemoembolization for hepatocellular carcinoma
    Huang, Y. -S.
    Chang, C. -C.
    Chang, Y. -C.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2014, 107 (06) : 487 - 488
  • [47] TRANSARTERIAL CHEMOEMBOLIZATION IN THE INTERMEDIATE STAGE OF HEPATOCELLULAR CARCINOMA: SURVIVAL ANALYSIS
    Tajibaev, T. K.
    Medeubekov, U. Sh
    Chormanov, A. T.
    Sagatov, I. Y.
    Kaniev, Sh A.
    Issamatov, B. K.
    Baimakhanov, B. B.
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (02): : 111 - 114
  • [48] Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization
    Ji, Suk Kyeong
    Cho, Yun Ku
    Ahn, Yong Sik
    Kim, Mi Young
    Park, Yoon Ok
    Kim, Jae Kyun
    Kim, Wan Tae
    KOREAN JOURNAL OF RADIOLOGY, 2008, 9 (06) : 534 - 540
  • [49] Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma
    Ni, Jia-Yan
    Sun, Hong-Liang
    Chen, Yao-Ting
    Luo, Jiang-Hong
    Chen, Dong
    Jiang, Xiong-Ying
    Xu, Lin-Feng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (46) : 17483 - 17490
  • [50] Relationship between FDG metabolism and survival after transarterial chemoembolization of the hepatocellular carcinoma.
    Piert, M
    Truebenbach, J
    Dohmen, B
    Bares, R
    Machulla, HJ
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 287P - 287P
12345